TCO-PEG4-VC-PAB-MMAE
Modify Date: 2024-09-25 10:46:19
TCO-PEG4-VC-PAB-MMAE structure
|
Common Name | TCO-PEG4-VC-PAB-MMAE | ||
|---|---|---|---|---|
| CAS Number | 2758671-45-1 | Molecular Weight | 1522.91 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C78H127N11O19 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TCO-PEG4-VC-PAB-MMAETCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE (HY-15162)[1]. |
| Name | TCO-PEG4-VC-PAB-MMAE |
|---|
| Description | TCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE (HY-15162)[1]. |
|---|---|
| Related Catalog | |
| In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
| References |
[1]. Yang Yi, et al. Preparation of site-specific antibody conjugates. Patent WO2022037665. |
| Molecular Formula | C78H127N11O19 |
|---|---|
| Molecular Weight | 1522.91 |